Chitta Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.12 M
as on 24-10-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 245.99 Cr
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit -1.24%
(FY 2023)
- Ebitda -1.24%
(FY 2023)
- Net Worth -0.25%
(FY 2023)
- Total Assets 20.24%
(FY 2023)
About Chitta Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹245.99 Cr.
Rama Namburi and Venkata Indukuri serve as directors at the Company.
- CIN/LLPIN
U15142TG2000PTC033373
- Company No.
033373
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2000
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chitta Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Namburi  | Director | 27-Jan-2000 | Current |
| Venkata Indukuri | Director | 30-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Chitta Bio-Tech.
Chitta Bio-Tech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.24% decrease in profit. The company's net worth dipped by a decrease of 0.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chitta Bio-Tech?
In 2022, Chitta Bio-Tech had a promoter holding of 88.86% and a public holding of 11.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shrutivinda Agro-Farms Private LimitedActive 19 years 11 months
Rama Namburi and Venkata Indukuri are mutual person
- Uttarashada Greenlands Private LimitedActive 24 years 10 months
Rama Namburi and Venkata Indukuri are mutual person
- Punarvasu Greenfields Private LimitedActive 24 years 10 months
Rama Namburi and Venkata Indukuri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2024 | ₹245.99 Cr | Open |
How Many Employees Work at Chitta Bio-Tech?
Unlock and access historical data on people associated with Chitta Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chitta Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chitta Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
